ARTICLE | Company News
Asahi Kasei sales and marketing update
December 5, 2011 8:00 AM UTC
Asahi launched Teribone teriparatide in Japan to treat osteoporosis in patients with a high risk of fracture. The National Health Insurance (NHI) price of the subcutaneous formulation of parathyroid hormone ( hPTH 1-34) is ¥12,971 ($167.33) for a 56.5 µg vial. ...